RecruitingNot ApplicableNCT05309850

Primary Prevention With the Lifestyle Tool

Primary Disease Prevention With the Lifestyle Tool


Sponsor

Region Skane

Enrollment

90,000 participants

Start Date

Apr 5, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

In this study participants will be randomized to use a digital lifestyle tool over three years or to a control group without access to the tool. The investigators will prospectively via clinical registries follow the incidence and development of type 2 diabetes and cardiovascular disease in those using the tool regularly and those in the control group.


Eligibility

Min Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether a lifestyle-based tool can help prevent type 2 diabetes and other chronic diseases in adults at risk. You may be eligible if: you are over 35 years old; and you have given your informed consent to participate. You may NOT be eligible if: you have type 1 diabetes, a rare inherited form of diabetes called MODY, or diabetes caused by another medical condition; you have a health condition or treatment that the study team believes would affect the results; or you have a personal connection to the study team, funders, or related organizations that could bias the outcomes. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALLifestyle tool

Regular use of the digital Lifestyle tool


Locations(1)

Skane University Hospital

Malmö, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05309850


Related Trials